Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles.
We recently noticed an error in the Table of our systematic review of
lipid lowering for the primary prevention of coronary heart disease in
diabetes (1). The Table reads that 1,037 patients with diabetes were
randomized in the WOSCOPS trial, when in fact the correct number of
diabetic patients is 76 (2). The results and conclusions of our
systematic review were not affected by this error.
Apoor S. Gami, MD
Victor Montori, MD, MSc
(1) Gami AS, Montori VM, Erwin PJ, Khan MA, Smith SA; Evidence in
Diabetes Enquiry System (EVIDENS) Research Group. Systematic review of
lipid lowering for primary prevention of coronary heart disease in
diabetes. BMJ 2003;326:528-529.
(2) Shepherd J, Cobbe S, Ford I, Isles CG, Lorimer AR, MacFarlane PW,
et al. Prevention of coronary heart disease with pravastatin in men with
hypercholesterolemia: West of Scotland Coronary Prevention Study Group. N
Engl J Med 1995;333:1301-7.